Anti-Cytochrome P450 3A4/CYP3A4 抗体 [EPR6202]
Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]
- RabMAb
- Recombinant
- 了解详情
4
(1 Review)
|
(16 Publications)
Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (ab124921) is a rabbit monoclonal antibody detecting Cytochrome P450 3A4/CYP3A4 in Western Blot, IP, IHC-P. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications
查看别名
CYP3A3, CYP3A4, Cytochrome P450 3A4, Albendazole monooxygenase (sulfoxide-forming), Albendazole sulfoxidase, CYPIIIA3, CYPIIIA4, Cholesterol 25-hydroxylase, Cytochrome P450 3A3, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450-PCN1, Nifedipine oxidase, Quinine 3-monooxygenase
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (AB124921)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human liver tissue sections labeling Cytochrome P450 3A4/CYP3A4 with purified ab124921 at 1/400 dilution (0.35 µg/ml). Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (AB124921)
ab124921 (unpurified), at a 1/100 dilution, staining Cytochrome P450 3A4/CYP3A4 in paraffin embedded Human liver tissue by Immunohistochemistry.
- IP
Unknown
Immunoprecipitation - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (AB124921)
ab124921 (purified) at 1/20 dilution (1ug) immunoprecipitating Cytochrome P450 3A4/CYP3A4 in Human liver lysates.
Lane 1 : Human liver lysates 10ug
Lane 2 (+) : ab124921 & Human liver lysates
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab124921 in Human liver lysates
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was at 1/1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (ab124921)
Predicted band size: 57 kDa
false
- WB
Unknown
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (AB124921)
All lanes:
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (ab124921) at 1/10000 dilution
All lanes:
Human fetal liver lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti rabbit at 1/2000 dilution
Predicted band size: 57 kDa
false
- WB
Unknown
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (AB124921)
HepG2 cells were incubated at 37°C for 48h with vehicle control (0 μM) and different concentrations of nicardipine hydrochloride (ab120531) in DMSO. Increased expression of Cytochrome P450 3A4/CYP3A4 (ab124921, unpurified) correlates with an increase in nicardipine hydrochloride concentration, as described in literature.
Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 10μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with ab124921 (unpurified) at 1/10000 dilution and ab9484 at 1 μg /ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.
All lanes:
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (ab124921)
Predicted band size: 57 kDa
true
Exposure time: 20min
- WB
Lab
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (AB124921)
This antibody fails to detect BOI in normal HepG2 cells which is positive reported by PMID 26089940 and 25141173
All lanes:
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (ab124921) at 1/1000 dilution
Lane 1:
Human liver lysates at 20 µg
Lane 2:
HepG2 (Human hepatocellular carcinoma epithelial cell), Whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa
Observed band size: 50 kDa
false
- WB
Supplier Data
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (AB124921)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
ab205606 was used as a tag loading control.
The detection of CYP3A4 recombinant protein or over -expressed protein with a C - terminal tag yielded a negative result because the immunogen of this product is located at the C - terminal of CYP3A4.
All lanes:
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (ab124921) at 1/1000 dilution
Lane 1:
293T cells transfected with an empty vector containing a Flag tag whole cell lysate at 20 µg
Lane 2:
293T cells transfected with a human CYP3A4 expression vector containing a N-terminal Flag tag whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 50 kDa
false
Exposure time: 1s
- OI-RD Scanning
Supplier Data
OI-RD Scanning - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (AB124921)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen) of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
不同偶联物与剂型 (4)
-
Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]
-
Biotin Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]
反应性数据
产品详情
What is this antibody validated in?
Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (ab124921) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P) in Human samples.
What is the molecular weight of Cytochrome P450 3A4/CYP3A4?
Anti-Cytochrome P450 3A4/CYP3A4 [EPR6202] (ab124921) specifically detects a band for Cytochrome P450 3A4/CYP3A4 (UniProt: P08684) at a molecular weight of 57kDa.
Trusted by the scientific community
Anti-Cytochrome P450 3A4/CYP3A4 [EPR6202] (ab124921) was first used in a scientific publication in 2012 and has been cited over 10 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR6202] also available for your convenience: ab124921, Carrier free - ab245774, Alexa Fluor® 647 - ab323439, Alexa Fluor® 488 - ab323440, Biotin - ab323530
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CYP3A4 is involved in the metabolism of approximately half of all drugs used in clinical settings making it one of the most significant enzymes in drug metabolism. It does not usually function as part of a larger complex but acts individually on various substrates. Besides xenobiotic metabolism CYP3A4 also metabolizes steroids and other endogenous molecules. Climbazole an antifungal agent is a substrate for CYP3A4 demonstrating the enzyme's broad substrate specificity within the body's complex biochemical environment.
Pathways
CYP3A4 plays a central role in the drug metabolism pathway and the synthesis and metabolism of steroids. These pathways involve other cytochrome P450 enzymes including CYP2D6 and CYP2C9 which often work alongside CYP3A4 to metabolize compounds. The pathway's coordinated activities ensure proper drug metabolism and hormone regulation. Understanding the involvement of CYP3A4 in these pathways is critical for drug development and determining drug-drug interactions.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (16)
Recent publications for all applications. Explore the full list and refine your search
Journal of xenobiotics 14:907-922 PubMed39051346
2024
Applications
Unspecified application
Species
Unspecified reactive species
Toxicological sciences : an official journal of the Society of Toxicology 199:227-245 PubMed38335931
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 25:105503 PubMed36404924
2022
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2022:2782702 PubMed35529917
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in bioengineering and biotechnology 10:826093 PubMed35372314
2022
Applications
Unspecified application
Species
Unspecified reactive species
Drug metabolism and disposition: the biological fate of chemicals 50:704-715 PubMed34949673
2021
Applications
Unspecified application
Species
Unspecified reactive species
Drug metabolism and disposition: the biological fate of chemicals 49:361-368 PubMed33674270
2021
Applications
Unspecified application
Species
Unspecified reactive species
Liver international : official journal of the International Association for the Study of the Liver 41:608-620 PubMed33179425
2020
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and experimental pharmacology & physiology 48:250-259 PubMed33048369
2020
Applications
Unspecified application
Species
Unspecified reactive species
Hepatic medicine : evidence and research 12:79-92 PubMed32607015
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com